Related by context. Frequent words. (Click for all words.) 74 QNEXA 71 MKC# 68 Dapagliflozin 67 R sorafenib tablets 67 Panzem R 67 Diamyd ® 67 Locteron ® 66 Pivotal Phase III 66 candidate brentuximab vedotin 66 liposomal formulation 65 Naproxcinod 65 6R BH4 65 Nexavar ® 65 Diamyd R 65 Phase III Clinical Trial 65 Icatibant 65 Initiate Phase 64 Mipomersen 64 GVAX R 64 Amrubicin 64 Genasense R oblimersen 64 gets USFDA nod 64 includes investigational compounds 64 Receives Orphan Drug Designation 64 Gabapentin GR 64 Ferumoxytol 64 Pirfenidone 64 pramlintide acetate injection 64 Rhucin ® 64 Pivotal Phase 64 forodesine 64 Clevudine 63 Cetrorelix 63 Ixempra 63 alvimopan 63 phenylalanine ammonia lyase 63 diabetic neuropathic pain 63 Argatroban 63 refractory chronic lymphocytic 63 non alcoholic steatohepatitis 63 Toctino R 63 PSN# [002] 63 Soliris TM eculizumab 63 phase IIb clinical 63 inflammatory autoimmune diseases 63 Belimumab 62 pitavastatin 62 Nanobody 62 Fibrillex TM 62 Omigard 62 inhaled formulation 62 Onalta 62 Initiates Phase II 62 BrachySil 62 Application MAA 62 Daclizumab 62 Recombinant Human 62 elotuzumab 62 Tesetaxel 62 Thiarabine 62 ezogabine 62 Empatic 62 Avanafil 62 Microplasmin 62 Pfizer Sutent 62 trodusquemine MSI 62 liprotamase 62 Alitretinoin 62 Vandetanib 62 Jevtana 62 Milnacipran 61 GRNVAC1 61 phase Ib 61 Rebif ® 61 Denufosol 61 KNS # 61 Alzhemed TM 61 Presents Positive 61 pseudobulbar affect PBA 61 Technosphere R 61 filgrastim 61 anticancer compound 61 Dasatinib 61 orBec 61 exocrine pancreatic insufficiency 61 ApoB SNALP 61 Ambrisentan 61 ALN TTR 61 Torisel 61 Menerba 61 teriflunomide 61 PEG PAL PEGylated recombinant 61 Patient Enrollment 61 FDA Accepts 61 DDP# 61 AVE# 61 primary hypercholesterolemia 61 Paraplatin 61 Traficet EN 61 retinal vein occlusion 61 methylnaltrexone